4 Metrics That Can Change Medicine
1 The Changing Landscape: ED visits have increased by about 3% per year over 12 years from 369 visits to 451 per 1000 population. The ED population is aging in line with the demographics of the country, and EDs need to prepare to meet the needs of seniors. 2 Less Trauma, More Sickness: Over the past 40 years, American emergency care has trended away from trauma and towards high acuity illness. Injuries now represent only 29% of patient encounters, with the biggest group of injured patients being the elderly. 3 Inpatient Admissions: Hospital inpatient admissions that are processed through the ED now stand at 68%. The need for precision in defining patient needs has resulted in more use of diagnostic tools in the ED, especially EKGs, MRI and ultrasound. The use of CT scanning appears to have plateaued. 4 LOS is Improving: Despite increased volumes, flow through the ED is improving. Flow is volume dependent, and boarding times for admitted patients is a key driver of overall flow. Median ED lengths of stay are decreasing, and only about 2% of patients walk away from the ED before treatment is complete. The post 4 Metrics That Can Change Medicine appeared first on Emergency Physicians Monthly.
CONCLUSION: As far as we know from the literature, this is the largest mesenteric fibromatosis tumour ever to be excised. We also noticed that this is the first reported case of the concomitant presence of mesenteric fibromatosis and non-Hodgkin lymphoma that is not related to any of the described risk factors. Further research is needed to establish what type of association this presentation may indicate. PMID: 32644849 [PubMed - as supplied by publisher]
Has anyone tried using the Butterly IQ ultrasound probe to perform nerve blocks or joint injections? I have done shoulder and hip joint injections using this probe, and while the anatomy showed up reasonably well, the needle (a regular BBraun 22g spinal needle) did not. I was able to get the injections done, but I am not sure how useful this device is for anything besides scanning. Anyone else have any thoughts on this probe for regional blocks and/or interventional procedures?
A Philips Healthcare team has converted shipping containers into offsite COVID-19...Read more on AuntMinnie.comRelated Reading: Philips reports ultrasound security issue Philips to collaborate with American Telemedicine Philips teams up with MD Anderson in oncology Philips launches Lumify ultrasound scanner in Japan Philips gets FDA nod for ultrasound for COVID-19
The purpose of this study was to develop and preliminarily evaluate phospholipid-shelled nanodroplets (NDs) encapsulating perfluoropentane (PFP) and radioactive 64Cu as a hybrid positron emission tomography (PET)-ultrasound (US) probe. PFP NDs were fabricated by mixing liquid-phase PFP with a phospholipid solution. The 64Cu was encapsulated into the NDs in a size-controlled manner by exploiting the hydrophobicity of 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) (64Cu-ATSM) using a vial mixer and an extruder.
FromCNN:"Handheld devices also cost much less than traditional ultrasound machines. The ones sold by Butterfly, GE and Philips range in price from around $2,000 to $5,000, whereas traditional devices can cost tens or even hundreds of thousands of dollars.The Butterfly iQ is currently equipped for 19 different types of scans and tests. A "major" limitation is the inability to perform the spectral Doppler test used to identify some more acute heart conditions."The Butterfly iQ costs $2,000. There is a first-year fee of $400:https://store.butterflynetwork.com/us/en/iq/configure/References:https://www.cnn.c...
Conditions: Cataract; Ultrasound Therapy; Complications Intervention: Device: Eye Scan Ultrasound System (ESUS) Sponsors: University of Coimbra; Fundação para a Ciência e a Tecnologia Not yet recruiting
This study showed that ultrasound triggering and GSH responsive PSP@MB might provide a novel strategy for OCSCs treatment via sonoporation and enhanced-endocytosis. PMID: 32627597 [PubMed - in process]
H-Scan ultrasound (US) is a new imaging technology that estimates the relative size of acoustic scattering objects and structures. The purpose of this study was to introduce a three-dimensional (3-D) H-scan US imaging approach for scatterer size estimation in volume space. Using a programmable research scanner (Vantage 256, Verasonics Inc, Kirkland, WA, USA) equipped with a custom volumetric imaging transducer (4 DL7, Vermon, Tours, France), raw radiofrequency (RF) data was collected for offline processing to generate H-scan US volumes.
CONCLUSIONS: The prevalence of incidental UVPT in a general gynaecology population was 3·0%. Several demographic and clinical factors were found to be associated with UVPT. This could help to identify women at risk of this condition, facilitate its early detection and development of evidence-based management strategies. PMID: 32638480 [PubMed - as supplied by publisher]
This study aimed to reevaluate the current prevalence of AAA in male patients with CHD, in order to assess whether CHD patients should be offered a targeted AAA ultrasound screening program. Patients and methods: The SCAN (Screening Cardiovascular Patients for Aortic Aneurysms) study prospectively evaluated the AAA prevalence in 1000 consecutive male CHD patients (70.1 ± 11.2 years) requiring any coronary intervention at an university hospital. All patients received transverse and longitudinal ultrasound scans of the abdominal aorta. Aortic diameter was assessed using the outer-to-outer measurement-te...